Who invested in Presage Biosciences?
Presage Biosciences's investors include Maveron, Celgene and Takeda Digital Ventures.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$20Mraised across 5 rounds since 2009, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $8.0M sold, first sale Mar 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.6M sold, first sale Jul 2011
No investor was named in the report.
Reported by presagebio.comSEC filing: $3.8M sold, first sale Mar 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Presage Biosciences's investors include Maveron, Celgene and Takeda Digital Ventures.
Presage Biosciences has raised $20M across 5 rounds since 2009. One round did not disclose an amount, so the total is a floor.
Presage Biosciences's most recent round was a Series D of $6.0M in Jul 2018.
Presage Biosciences's largest round on record is $8.0M (Venture), in Mar 2013.
Presage Biosciences's first round on record, in Nov 2009, was backed by Maveron.
Presage Biosciences's latest named round is a Series D, in Jul 2018.
Presage Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.